Articles related to CRITICAL CARE

It’s clear that addressing the carbon footprint in intensive care units (ICUs) is an important area of concern in tackling the climate crisis. As ICUs are a carbon hotspot, various measures can be taken to reduce their impact on the environment without compromising patient care.

In this video, Zack Shinar, MD, discusses the future of cardiac arrest and the role of extracorporeal membrane oxygenation (ECMO) in the emergency department (ED). Dr. Shinar is a leading expert in ECMO and has been instrumental in developing new protocols for its use in the ED. Dr. Shinar begins by discussing the current state of CPR. He notes that CPR is only effective in about 10% of cases, and that even when it is successful, patients often suffer significant brain damage. He then discusses ECMO, which is a life-support machine that can oxygenate the blood outside of the body. ECMO has been shown to be effective in saving the lives of patients with cardiac arrest, and Dr. Shinar believes that it should be used more widely in the ED. Dr. Shinar then discusses the challenges of using ECMO in the ED. He notes that ECMO is a complex procedure that requires specialized training and equipment. He also notes that ECMO can be expensive, and that it is not always available in all hospitals.

The first set of guidelines for critical illness-related corticosteroid insufficiency (CIRCI) was published in 2008. In this review of critical illness-related corticosteroid insufficiency, the author reviews the current thinking regarding this relatively newly defined complex and the changing recommendations for management.

There is plenty of psychological material that can be examined in the palliative care encounter, despite the fact that it is frequently practiced by doctors with backgrounds outside of mental health training. This case presentation and associated discussion to introduce the psychological aspects of palliative medicine to psychiatrists and psychotherapists is based on the palliative care consultation sought with the multiple objectives of alleviating a patient’s severe death anxiety and persistent dyspnea, as well as helping in the clarification of his end-of-life wishes.

Neuroleptic malignant syndrome (NMS), which has a high morbidity and death rate, is one of the deadly side effects of antipsychotic or antiemetic drugs. The common drugs linked to NMS are identified in this article, along with the etiology of the condition, clinical symptoms, risk factors, laboratory and imaging results, and treatment options.

A 66-year-old male presented with a 5-day history of progressive shortness of breath,right-sided pleurisy, and productive cough. He also has night sweats and malaise, but nofevers, chills, or hemoptysis. Review his medical history and choose your course ofaction.